14/06/2023
Letters to the Editor
Letters to the Editor
To start, some comments on mega-cap stocks and artificial intelligence during the narrowest market leadership on record. Then, since it’s the beginning of summer, it’s time for some of my unsolicited letters to Barron’s, MSNBC, the “No Labels” US political movement, the Federal Housing Finance Agency, the Urban Institute, the National Housing Conference and Jeep. Apologies in advance to all recipients.
IMPORTANT INFORMATION
This report uses rigorous security protocols for selected data sourced from Chase credit and debit card transactions to ensure all information is kept confidential and secure. All selected data is highly aggregated and all unique identifiable information, including names, account numbers, addresses, dates of birth, and Social Security Numbers, is removed from the data before the report’s author receives it. The data in this report is not representative of Chase’s overall credit and debit cardholder population.
The views, opinions and estimates expressed herein constitute Michael Cembalest’s judgment based on current market conditions and are subject to change without notice. Information herein may differ from those expressed by other areas of J.P. Morgan. This information in no way constitutes J.P. Morgan Research and should not be treated as such.
The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from J.P. Morgan or any of its subsidiaries to participate in any of the transactions mentioned herein. Any forecasts, figures, opinions or investment techniques and strategies set out are for information purposes only, based on certain assumptions and current market conditions and are subject to change without prior notice. All information presented herein is considered to be accurate at the time of production. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine, together with their own professional advisers, if any investment mentioned herein is believed to be suitable to their personal goals. Investors should ensure that they obtain all available relevant information before making any investment. It should be noted that investment involves risks, the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Both past performance and yields are not reliable indicators of current and future results.
Non-affiliated entities mentioned are for informational purposes only and should not be construed as an endorsement or sponsorship of J.P. Morgan Chase & Co. or its affiliates.
For J.P. Morgan Asset Management Clients:
J.P. Morgan Asset Management is the brand for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with our privacy policies at https://am.jpmorgan.com/global/privacy.
ACCESSIBILITY
For U.S. only: If you are a person with a disability and need additional support in viewing the material, please call us at 1-800-343-1113 for assistance.
This communication is issued by the following entities:
In the United States, by J.P. Morgan Investment Management Inc. or J.P. Morgan Alternative Asset Management, Inc., both regulated by the Securities and Exchange Commission; in Latin America, for intended recipients’ use only, by local J.P. Morgan entities, as the case may be.; in Canada, for institutional clients’ use only, by JPMorgan Asset Management (Canada) Inc., which is a registered Portfolio Manager and Exempt Market Dealer in all Canadian provinces and territories except the Yukon and is also registered as an Investment Fund Manager in British Columbia, Ontario, Quebec and Newfoundland and Labrador. In the United Kingdom, by JPMorgan Asset Management (UK) Limited, which is authorized and regulated by the Financial Conduct Authority; in other European jurisdictions, by JPMorgan Asset Management (Europe) S.à r.l. In Asia Pacific (“APAC”), by the following issuing entities and in the respective jurisdictions in which they are primarily regulated: JPMorgan Asset Management (Asia Pacific) Limited, or JPMorgan Funds (Asia) Limited, or JPMorgan Asset Management Real Assets (Asia) Limited, each of which is regulated by the Securities and Futures Commission of Hong Kong; JPMorgan Asset Management (Singapore) Limited (Co. Reg. No. 197601586K), which this advertisement or publication has not been reviewed by the Monetary Authority of Singapore; JPMorgan Asset Management (Taiwan) Limited; JPMorgan Asset Management (Japan) Limited, which is a member of the Investment Trusts Association, Japan, the Japan Investment Advisers Association, Type II Financial Instruments Firms Association and the Japan Securities Dealers Association and is regulated by the Financial Services Agency (registration number “Kanto Local Finance Bureau (Financial Instruments Firm) No. 330”); in Australia, to wholesale clients only as defined in section 761A and 761G of the Corporations Act 2001 (Commonwealth), by JPMorgan Asset Management (Australia) Limited (ABN 55143832080) (AFSL 376919). For all other markets in APAC, to intended recipients only.
For J.P. Morgan Private Bank Clients:
ACCESSIBILITY
J.P. Morgan is committed to making our products and services accessible to meet the financial services needs of all our clients. Please direct any accessibility issues to the Private Bank Client Service Center at 1-866-265-1727.
LEGAL ENTITY, BRAND & REGULATORY INFORMATION
In the United States, bank deposit accounts and related services, such as checking, savings and bank lending, are offered by JPMorgan Chase Bank, N.A. Member FDIC.
JPMorgan Chase Bank, N.A. and its affiliates (collectively “JPMCB”) offer investment products, which may include bank-managed investment accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC (“JPMS”), a member of FINRA and SIPC. Annuities are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPM. Products not available in all states.
In Germany, this material is issued by J.P. Morgan SE, with its registered office at Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main, Germany, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). In Luxembourg, this material is issued by J.P. Morgan SE – Luxembourg Branch, with registered office at European Bank and Business Centre, 6 route de Treves, L-2633, Senningerberg, Luxembourg, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Luxembourg Branch is also supervised by the Commission de Surveillance du Secteur Financier (CSSF); registered under R.C.S Luxembourg B255938. In the United Kingdom, this material is issued by J.P. Morgan SE – London Branch, registered office at 25 Bank Street, Canary Wharf, London E14 5JP, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – London Branch is also supervised by the Financial Conduct Authority and Prudential Regulation Authority. In Spain, this material is distributed by J.P. Morgan SE, Sucursal en España, with registered office at Paseo de la Castellana, 31, 28046 Madrid, Spain, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE, Sucursal en España is also supervised by the Spanish Securities Market Commission (CNMV); registered with Bank of Spain as a branch of J.P. Morgan SE under code 1567. In Italy, this material is distributed by J.P. Morgan SE – Milan Branch, with its registered office at Via Cordusio, n.3, Milan 20123, Italy, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Milan Branch is also supervised by Bank of Italy and the Commissione Nazionale per le Società e la Borsa (CONSOB); registered with Bank of Italy as a branch of J.P. Morgan SE under code 8076; Milan Chamber of Commerce Registered Number: REA MI 2536325. In the Netherlands, this material is distributed by J.P. Morgan SE – Amsterdam Branch, with registered office at World Trade Centre, Tower B, Strawinskylaan 1135, 1077 XX, Amsterdam, The Netherlands, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Amsterdam Branch is also supervised by De Nederlandsche Bank (DNB) and the Autoriteit Financiële Markten (AFM) in the Netherlands. Registered with the Kamer van Koophandel as a branch of J.P. Morgan SE under registration number 72610220. In Denmark, this material is distributed by J.P. Morgan SE – Copenhagen Branch, filial af J.P. Morgan SE, Tyskland, with registered office at Kalvebod Brygge 39-41, 1560 København V, Denmark, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Copenhagen Branch, filial af J.P. Morgan SE, Tyskland is also supervised by Finanstilsynet (Danish FSA) and is registered with Finanstilsynet as a branch of J.P. Morgan SE under code 29010. In Sweden, this material is distributed by J.P. Morgan SE – Stockholm Bankfilial, with registered office at Hamngatan 15, Stockholm, 11147, Sweden, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Stockholm Bankfilial is also supervised by Finansinspektionen (Swedish FSA); registered with Finansinspektionen as a branch of J.P. Morgan SE. In France, this material is distributed by JPMCB, Paris branch, which is regulated by the French banking authorities Autorité de Contrôle Prudentiel et de Résolution and Autorité des Marchés Financiers. In Switzerland, this material is distributed by J.P. Morgan (Suisse) SA, with registered address at rue de la Confédération, 8, 1211, Geneva, Switzerland, which is authorised and supervised by the Swiss Financial Market Supervisory Authority (FINMA), as a bank and a securities dealer in Switzerland. Please consult the following link to obtain information regarding J.P. Morgan’s EMEA data protection policy: https://www.jpmorgan.com/privacy.
In Hong Kong, this material is distributed by JPMCB, Hong Kong branch. JPMCB, Hong Kong branch is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission of Hong Kong. In Hong Kong, we will cease to use your personal data for our marketing purposes without charge if you so request. In Singapore, this material is distributed by JPMCB, Singapore branch. JPMCB, Singapore branch is regulated by the Monetary Authority of Singapore. Dealing and advisory services and discretionary investment management services are provided to you by JPMCB, Hong Kong/Singapore branch (as notified to you). Banking and custody services are provided to you by JPMCB Singapore Branch. The contents of this document have not been reviewed by any regulatory authority in Hong Kong, Singapore or any other jurisdictions. You are advised to exercise caution in relation to this document. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. For materials which constitute product advertisement under the Securities and Futures Act and the Financial Advisers Act, this advertisement has not been reviewed by the Monetary Authority of Singapore. JPMorgan Chase Bank, N.A. is a national banking association chartered under the laws of the United States, and as a body corporate, its shareholder’s liability is limited.
With respect to countries in Latin America, the distribution of this material may be restricted in certain jurisdictions. We may offer and/or sell to you securities or other financial instruments which may not be registered under, and are not the subject of a public offering under, the securities or other financial regulatory laws of your home country. Such securities or instruments are offered and/or sold to you on a private basis only. Any communication by us to you regarding such securities or instruments, including without limitation the delivery of a prospectus, term sheet or other offering document, is not intended by us as an offer to sell or a solicitation of an offer to buy any securities or instruments in any jurisdiction in which such an offer or a solicitation is unlawful. Furthermore, such securities or instruments may be subject to certain regulatory and/or contractual restrictions on subsequent transfer by you, and you are solely responsible for ascertaining and complying with such restrictions. To the extent this content makes reference to a fund, the Fund may not be publicly offered in any Latin American country, without previous registration of such fund’s securities in compliance with the laws of the corresponding jurisdiction. Public offering of any security, including the shares of the Fund, without previous registration at Brazilian Securities and Exchange Commission— CVM is completely prohibited. Some products or services contained in the materials might not be currently provided by the Brazilian and Mexican platforms.
JPMorgan Chase Bank, N.A. (JPMCBNA) (ABN 43 074 112 011/AFS Licence No: 238367) is regulated by the Australian Securities and Investment Commission and the Australian Prudential Regulation Authority. Material provided by JPMCBNA in Australia is to “wholesale clients” only. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Corporations Act 2001 (Cth). Please inform us if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.
JPMS is a registered foreign company (overseas) (ARBN 109293610) incorporated in Delaware, U.S.A. Under Australian financial services licensing requirements, carrying on a financial services business in Australia requires a financial service provider, such as J.P. Morgan Securities LLC (JPMS), to hold an Australian Financial Services Licence (AFSL), unless an exemption applies. JPMS is exempt from the requirement to hold an AFSL under the Corporations Act 2001 (Cth) (Act) in respect of financial services it provides to you, and is regulated by the SEC, FINRA and CFTC under U.S. laws, which differ from Australian laws. Material provided by JPMS in Australia is to “wholesale clients” only. The information provided in this material is not intended to be, and must not be, distributed or passed on, directly or indirectly, to any other class of persons in Australia. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Act. Please inform us immediately if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.
This material has not been prepared specifically for Australian investors. It:
May contain references to dollar amounts which are not Australian dollars;
May contain financial information which is not prepared in accordance with Australian law or practices;
May not address risks associated with investment in foreign currency denominated investments; and
Does not address Australian tax issues.
Listen to Podcast
Letters to the Editor
Comments on mega-cap stocks and artificial intelligence. Then, it’s time for some of my unsolicited letters to Barron’s, MSNBC, “No Labels”, FHFA and more.
[START RECORDING]
FEMALE VOICE: This podcast has been prepared exclusively for institutional, wholesale, professional clients and qualified investors only as defined by local laws and regulations. Please read other important information which can be found on the link at the end of the podcast episode.
[MUSIC]
MR. MICHAEL CEMBALEST: Hello and welcome to the June Eye on the Market podcast. This one’s called Letters to the Editor for reasons I will explain. In the first part of the piece this week we talk about something everybody’s talking about which is the dominance of these mega cap stocks again this year which are up around 80% while the rest of the market is up like 1%.
So the largest 7 companies now represent the highest share of overall market cap on record. The percentage of stocks beating the S&P over the last three months, on a 3-month basis, is around 10% which is even lower than the narrow market leadership in March of 2000.
So this is a very narrowly driven market. What’s driving this is—the good news is NVIDIA and Meta earnings have sharply increased which is driving part of what’s going on but there’s a lot of multiple expansion across the board with NVIDIA, Apple and Microsoft priced at the high end of their historical ranges.
So there’s a lot of mega cap bullishness in the market right now. A lot of that is fueled by this perception of AI exposure. We took a look at one of the indicative AI ETFs. It’s called Dollar Sign Chat Generative AI. It’s up 70% this year. Of the two-thirds of the stocks in this ETF that actually have earnings, they traded at about a PE of 30 which is not crazy for these kind of growth stocks. The issue is that the other third of them have infinite PEs ‘cause they have no earnings at all or trivially positive earnings that create nonsense PEs.
So there’s a lot—the large langue model revolution is going to have to live up to the high end of expectations to justify this. You know earlier this year we looked at how these models were doing compared to some complicated challenges in terms of linguistics and math and biology and physics and logic and image recognition. And this project was updated— it’s a multi-firm effort with over 200 tasks. As of last summer it was still performing well below the average human far below the best human.
But a few months is a long time in this space. And GPT 4 has improved a lot even compared to GPT 3.5. And you know I believe some of the potential for productivity gains and job force reductions here. You know a lot of large language models, even if they’re just conventional wisdom machines, there’s billions of dollars of market cap and millions of employees in industries which traffic in the packaging and emission of conventional wisdom every day.
So just be aware that the AI hype machine is in full swing right now alongside whatever real productivity gains all of this may ultimately result in.
Anyway. We have some charts in here to kind of put some pictures around that.
So it’s… it’s the beginning of summer so it’s time for some of my cranky, unsolicited letters to various organizations. And that’s what the rest of the Eye on the Market and this podcast are about.
My first letter is to Barron’s which wrote tons of really bullish articles on cell and gene therapy investments at the peak in biologic stocks in 2021. And then the sector completely imploded. And we scanned all 3,600 ETFs in the U.S. and biotech was on a very short list of things that soared and crashed the most. Barron’s is now writing that given how hard the sector has fallen it could be a good time to buy. I understand the general sentiment. I’m always more interested in something after a fall than at its peak.
My concern is that during the peak in biotech stocks in 2021, where are all of the other Barron’s articles on some of the challenges and risks associated with investments in cell and gene therapies. These things represent just 1% of all drug sales and drug trials. 90% of the trials are just Phase 1 or 2 and unlikely to be commercialized.
The approval timeframe process for this stuff is much longer than regular drugs which is already 9 years. The success rates are low. The prices for some of these things are over $2 million since they target such small populations. And there are some risks associated with the viral vectors used to deliver some of these treatments.
So I just don’t recall Barron’s ever writing about any of that. Now. Some more of these things may be approved in the U.S. and Europe this year. The first CRISPR treatments for sickle cell and some other diseases may be approved. Some of the ones up for review target larger populations like macular degeneration. I’m sure a lot of people listening to this podcast know somebody that suffers for (sic) that.
And there’s also some really good news from the structural biology, essentially researchers are finally able to use artificial intelligence to identify potential pathways to treat things like liver cancer. Predict the three dimensional structure of the protein that’s associated with it. And then develop a pathway, a compound, to treat it. And they did that within 30 days.
So the speed of some of these things is unprecedented. But the bottom line is that as the paper of record on financial markets, the track record for Barron’s here in promoting this sector corresponded way more with the peak in these stocks than with the trough. And that’s something that they should be paying attention to just as much as any investor would.
My next letter is to the people that produce a lot of the MSNBC shows. I don’t watch them. My wife, Rachel, wants me to watch them with her but I generally refuse to do it. They had some coverage recently of the natural gas stove issue. And they were mocking and dismissing the idea that the government is coming for your gas stoves.
Now while that language is somewhat hyperbolic, New York did pass a law that will ban natural gas in new buildings as early as 2026 for stoves, furnaces and heating. Los Angeles has passed a similar law. And Denver, San Francisco, Seattle have enacted natural gas bans for heating although they may allow stoves. And this is a real thing. This wasn’t just culture war material which is what all of the MSNBC hosts described that it was.
This is a huge opportunity missed here, right? Because if somebody says, oh my god, the government is coming for your stoves, you could go—you could discuss the improvements in heat pumps and induction stoves and how they contribute to decarbonization. You could talk about all the federal and state subsidies for people that purchase them. You could talk about how heat pumps are already overtaking gas furnaces in the U.S. You could talk about possible strains on the grid from electrifying heating and transportation at the same time. And you know you could talk about some of the legislation that’s been passed in certain states to preempt laws that prohibit gas.
But you know the bottom line was this was a huge opportunity missed here. The quotes that we include from some of these MSNBC hosts was—were things like, well, you know, the people that watch those shows have been addicted to the culture of lies and conspiracy theories. Maybe at times that’s true but on this issue it wasn’t and this was a huge opportunity missed and a mistake.
Another letter I wrote was to something called the No Labels Movement. The No Labels Movement is a movement that plans to run a unity ticket after Super Tuesday primaries if they believe they can win and if they believe that most—that both major party nominees are !unpopular!. Well that’s a lot of ifs and that’s a lot of subjective judgements.
Third party candidates can change very close elections and we have some charts in here that show over the last 50 years or so a bunch of times when just a few percent of a third party candidate’s votes switching to the second place candidate could have shifted the outcome in that state.
The other thing to think about is if a mildly successful unity ticket were able to get enough electoral votes that prevented the other two parties from reaching 270, we would have what’s called a 12th amendment contingent election which would be held. And every state delegation to the House would get one vote. So Alaska would get one vote and California would get one vote. And presumably those votes would be decided based on the partisan balance within those House delegations.
And currently, there are 26 House delegations controlled by the GOP, 21 by Democrats, and 3 ties. So if you ended up with a contingent election scenario, if the composition of the House in 2024 is the same as it is today, the GOP would control this outcome. So the bottom line here is that as tempting as it is to think about unity tickets and this No Labels Movement, history suggests that this movement will either have to exercise a lot of discipline and not run a unity slate at the 11th hour despite all the time and effort they spend on it or they might move forward in an environment of a lot of uncertainty with all sorts of potential, unanticipated electoral outcomes.
We cite some research here showing what could have happened in certain years if the votes shifted by certain candidates and certainly the year 2000 is a good example of that. If both Nader and Buchanan hadn’t run, Gore wins Florida and the presidency based on the model distributions of those votes. And that wasn’t the only year that something like that could happen.
We also have a page in here on some good news if you’re concerned about the process. One of the things you might remember from 2020 is that there was a lot of unsubstantiated assertions about the powers of the vice president at the joint session on January 6th.
There were some electrical count act reforms passed at the end of last year that clarifies that the role of the vice president is purely a ceremonial one and makes all sorts of other changes to the process which you can read about which make it effectively harder for Congress to disregard legitimately submitted slates. And it makes it harder for the state legislatures to submit bogus slates. So for anybody concerned about the process in the last election, these election—these electoral count act reforms passed late last year are a good thing.
The longest letter I wrote is to the Federal Housing and Finance Administration. I’m not going to go into too much detail here. They reacted very negatively to some press articles that commented on the fact that the—basically the fees that are charged for when people take out a GSE-eligible mortgage. There are subsidies in those, in those fees where higher quality borrowers at times are financing lower quality borrowers and riskier loans.
The FHFA strongly disagrees with that. I strongly disagree with the FHFA. And for anybody interested in the intestinal details of how the GSEs function and how the—and how these fees changed and what happens with private mortgage insurance and fee waivers and things like that, enjoy. I wrote a 3- page letter here.
I do conclude though with something that everybody should be aware of which is there is a lack of affordable homes. And if you’re trying to solve the problem with not enough affordable homes, I think that more supply is a better solution than more subsidies for people to buy those expensive homes.
And why is there a lack of affordable homes? There’s a chart in here that will--is simply amazing. Small homes, less than 1,400 square feet, used to be 35% of all housing completions. Certainly that’s the number they were when I was in college.
Now they’re 7%. They went from 35% to 7% of housing completions because of all sorts of large lot zoning rules, restrictions on multifamily housing, regulatory costs, community litigation. That’s the stuff. That’s hard work but that’s—those are the kind of structural reforms which are needed to get rid of the logjam in housing supply in both rural, suburban, and urban locations. So there’s some charts and data on there.
And then to conclude, pardon me, to conclude I wrote a letter to Jeep about my new Wrangler plug-in hybrid. I loved my 2012 Jeep Wrangler. It aged out. I drove it pretty hard and it was time to get a new car. And instead of buying a regular internal combustion engine version, Rachel convinced me to get the 4-door plug-in hybrid which has been a bumpy ride so far with two recalls, a failed electric battery and things like that.
So you can read about the details. I’m a big fan of plug-in hybrids since I don’t have access to a wall charger in New York City. And given the potential for these things to reduce emissions if you religiously charge them, but they have to stay out of the shop.
Anyway, thank you very much for listening. Take a look at the note. Lots of fun charts and there’s even a mention of Dua Lipa [phonetic] at the end of the piece. So thanks for listening and I’ll see you next time.
FEMALE VOICE: Michael Cembalest, Eye on the Market, offers a unique perspective on the economy, current events, markets, and investment portfolios and is a production of JPMorgan Asset and Wealth Management.
Michael Cembalest is the chairman of Market and Investment Strategy for JPMorgan Asset Management and is one of our most renowned and provocative speakers. For more information, please subscribe to the Eye on the Market by contacting your JPMorgan representative.
If you’d like to hear more, please explore episodes on iTunes or on our website. This podcast is intended for informational purposes only and is a communication on behalf of JPMorgan Institutional Investments, Incorporated.
Views may not be suitable for all investors and are not intended as personal investment advice or as solicitation or recommendation. Outlooks and past performance are never guarantees of future results. This is not investment research.
Please read other important information which can be found at www.jpmorgan.com/disclaimer-eotf (audio cuts off on last syllable).
[END RECORDING]